Over-encapsulation of comparator products is now a widely accepted procedure used throughout the clinical supplies industry. While the process itself may appear relatively straightforward, blinding of materials for clinical supplies can be complex and must adhere to strict good manufacturing practices (GMP). In this whitepaper, Richard Shannon, Almac Clinical Services, discusses the mechanisms and techniques currently available to Pharma companies to promote successful completion of over-encapsulation requirements for clinical supplies.
- Temperature-Controlled IMP Distribution Challenges
- Forecasting strategies to optimize clinical trials
- Blinding Techniques for Inhaler Devices - Development of a Novel Blinding Methodology for a Market Leading DPI
- A Configurable & Cost-effective Randomization Solution for Patient & Supply Chain Management - aXcess™